Acute Graft-Versus-Host Disease (GVHD)

Jun 23, 2017 by in HEMATOLOGY Comments Off on Acute Graft-Versus-Host Disease (GVHD)

Organ Clinical manifestations Histologic findings Alternate diagnoses Skin Erythematous maculopapular rash involving the palms, soles, pinnae, spreading to the trunk and later extremities. +/− pruritis. Bullae/desquamation in severe cases Basal…

read more

Long-Term Follow-Up and Survivorship

Jun 23, 2017 by in HEMATOLOGY Comments Off on Long-Term Follow-Up and Survivorship

NCI office of Cancer Survivorship http://​cancercontrol.​cancer.​gov/​ocs/​ LiveStrong™ Foundation http://​www.​livestrong.​org National Marrow Donor Program http://​www.​bethematch.​org National Bone Marrow Transplant Link http://​www.​nbmtlink.​org HSCT survivors are faced with a significantly increased risk for…

read more

Palliative Care

Jun 23, 2017 by in HEMATOLOGY Comments Off on Palliative Care

Antiemetic agent Action Dosage Side effects Anticholinergics/ antimuscarinics A direct depressant action on the VC. An antispasmodic action on the gut. Useful for motion sickness and post-operative N/V (PONV) Hyoscine…

read more

Posttransplant Relapse

Jun 23, 2017 by in HEMATOLOGY Comments Off on Posttransplant Relapse

© Springer Science+Business Media, LLC 2015Richard T. Maziarz and Susan Schubach Slater (eds.)Blood and Marrow Transplant Handbook10.1007/978-3-319-13832-9_32 32. Posttransplant Relapse Marlise R. Luskin1 and David L. Porter1   (1) Division of Hematology/Oncology and the Abramson Cancer Center, Perelman…

read more

Graft Failure

Jun 23, 2017 by in HEMATOLOGY Comments Off on Graft Failure

Type of product TNC/kg body weight of recipient CD34 + cell/kg body weight of recipient Bone marrow > 2 × 108   Peripheral blood stem cells > 2 × 108 > 3 × 106 Double cord blood—each unit > 2 × 107  …

read more

Secondary Malignancies

Jun 23, 2017 by in HEMATOLOGY Comments Off on Secondary Malignancies

  Alkylating agents Topoisomerase II inhibitors Latency 3–8 years 2–3 years Incidence 2–20 % 2–12 % Myelodysplastic phase Present Absent FAB type M1, M2 M4, M5 Cytogenetics 5-, 7-, 5q-, 7q- 11q23…

read more

Psychiatric Complications

Jun 23, 2017 by in HEMATOLOGY Comments Off on Psychiatric Complications

Patient condition Suggested antidepressant drug of choice Depression with anxiety or agitation Paroxetine (Paxil®) Depression with lethargy and amotivation Fluoxetine (Prozac®), buproprion (Wellbutrin®), or venlafaxine (Effexor®) Preexisting cardiac disease Congestive…

read more

Women’s Hormonal Health Issues

Jun 23, 2017 by in HEMATOLOGY Comments Off on Women’s Hormonal Health Issues

Composition Product name FDA-approved dosage Vaginal creams 17β-estradiol Estrace vaginal cream® Initial: 2–4 g/day for 1–2 weeks maintenance: 1 g/1–3 times/week Conjugated estrogens Premarin vaginal cream® For VVA: 0.5–2 g/day for 21 day…

read more

Thrombotic Microangiopathies

Jun 23, 2017 by in HEMATOLOGY Comments Off on Thrombotic Microangiopathies

Ruutu T, Barosi G, Benjamin RJ, Clark RE, George JN, Gratwohl A, et al. European Group for Blood and Marrow Transplantation; European LeukemiaNet. Diagnostic criteria for hematopoietic stem cell transplant-associated microangiopathy:…

read more

Endocrine Complications in Childhood Cancer Survivors

Jun 23, 2017 by in HEMATOLOGY Comments Off on Endocrine Complications in Childhood Cancer Survivors

Alkylating agents Busulfan Cisplatin Cyclophosphamide Ifosfamide Mechlorethamine Melphalan Nitrosureas BCNU (carmustine) CCNU (lomustine) Procarbazine Thiotepa Primary factors associated with late endocrine complications are as follows: 1. Radiotherapy: the involved field,…

read more
Get Clinical Tree app for offline access